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Abstract
Purpose: Vitamin D deficiency is a common condition that is associated with diabetes and insulin resistance. However, the
association between vitamin D and insulin resistance has not been fully studied, especially in the general adolescent
population. Therefore, we assessed the association between serum 25-hydroxyvitamin D [25(OH)D] level and insulin
resistance among apparently healthy Korean adolescents.
Methods: A total of 260 (135 male and 125 female) adolescents in a rural high school were assessed for serum 25(OH)D,
fasting plasma glucose, and insulin. All of the participants were aged 15 to 16 years old, and without known hypertension or
diabetes. Serum 25(OH)D was analyzed both as a continuous and categorical variable in association with insulin resistance.
Insulin resistance was estimated by homeostasis model assessment (HOMA-IR). Increased insulin resistance was
operationally defined as a HOMA-IR value higher than the sex-specific 75th percentile.
Results: In male adolescents, every 10 ng/ml decrease in 25(OH)D level was associated with a 0.25 unit increase in HOMA-IR
(p = 0.003) after adjusting for age and BMI. Compared to those in the highest quartile, male adolescents in the lowest
25(OH)D quartile were at significantly higher risk for insulin resistance: unadjusted odds ratio 4.06 (95% CI, 1.26 to 13.07);
age and BMI adjusted odds ratio 3.59 (95% CI, 1.03 to 12.57). However, 25(OH)D level, either in continuous or categorical
measure, was not significantly associated with insulin resistance among female adolescents.
Conclusions: This study suggests that serum 25(OH)D level may be inversely associated with insulin resistance in healthy
male adolescents.
Citation: Choi DP, Oh SM, Lee J-M, Cho HM, Lee WJ, et al. (2014) Serum 25-Hydroxyvitamin D and Insulin Resistance in Apparently Healthy Adolescents. PLoS
ONE 9(7): e103108. doi:10.1371/journal.pone.0103108
Editor: Joseph Devaney, Children’s National Medical Center, Washington, United States of America
Received January 26, 2014; Accepted June 26, 2014; Published July 29, 2014
Copyright:  2014 Choi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) grant funded by the
Ministry of Education, Science and Technology (MEST) (No. 2010-0007860) and by a faculty research grant of Yonsei University College of Medicine for 2010 (6-
2010-0164). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* Email: hckim@yuhs.ac
Introduction
Vitamin D is an important fat-soluble vitamin that functions in
calcium and phosphorus homeostasis and affects bone minerali-
zation. Functions of vitamin D are not limited to skeletal effects,
and a non-skeletal action under active investigation is the role of
vitamin D in insulin or glucose metabolism [1]. Vitamin D status
may play a functional role in glucose homeostasis as in vitro and in
vivo studies have provided biological evidence of its effects on
insulin secretion and insulin sensitivity [2–6]. Several epidemio-
logical studies have reported associations between low vitamin D
status, as indicated by circulating serum 25-hydroxyvitamin D
[25(OH)D], and the risk of type 2 diabetes [7–10], although others
have not found such an association [11,12]. A study of the Third
National Health and Nutrition Examination Survey (NHANES
III) showed an inverse association between serum 25(OH)D level,
insulin resistance, and diabetes in non-Hispanic whites and
Mexican Americans, but not in non-Hispanic blacks [13]. Serum
25(OH)D level was inversely associated with insulin resistance in a
study of Chinese individuals [14], but was not associated with
insulin resistance or beta cell function in a study of the Canadian
Cree [12].
An association between hypovitaminosis D and insulin resis-
tance has also been reported in overweight or obese adolescents
[15–19], but the association was not observed in the general
adolescent population [20]. The association between vitamin D
and insulin resistance has not been fully explored, especially in
healthy adolescents. Therefore, we investigated the association
between serum 25(OH)D level and insulin resistance among
apparently healthy Korean adolescents.
Materials and Methods
Study population
We conducted a cross-sectional analysis of baseline data
collected for an adolescent cohort study. All first-year students of
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a high school in a rural community in South Korea were invited to
participate in the cohort study. Among the total 283 first-year
students, 268 students agreed to participate in the study between
May 30 and June 22, 2011. After exclusion of seven individuals
who were missing serum 25(OH)D measurements and one
individual with diagnosed hypertension, 260 students were
included for this analysis. All participants were aged between 15
and 16 years (mean age 15.9 years) and had not been previously
diagnosed with diabetes mellitus. Written informed consent was
obtained from each participant and his/her parent or guardian.
Informed consent forms were distributed to eligible students at
least one week prior to the examination, so the participating
students and their parents had enough time to understand the
purpose and process of the study. On the day of examination,
research staff checked whether each consent form was completed
and signed by the student as well as his/her parent or guardian.
The study protocol and consent procedure was approved by the
Institutional Review Board of Severance Hospital at Yonsei
University College of Medicine (Approval No. 4-20100169).
Measurements
Health-related lifestyle, personal and family medical history
were evaluated with self-report questionnaires. Smokers were
defined as participants who smoked more than 100 cigarettes in
their lifetime. Drinkers were defined as participants who consume
alcoholic beverage at least once a month over the last year.
Regular exercise was defined as physical activity on a regular basis
(at least once a week for 30 minutes at moderate intensity)
regardless of indoor or outdoor exercise. Anthropometric
measures, performed using the same devices throughout this
study, were taken by a trained examiner. Standing height was
measured to the nearest 0.1 cm on a stadiometer, and body weight
was measured to the nearest 0.1 kg on a digital scale (Seca 763;
SECA, Hamburg, Germany) while wearing the school uniform.
Body mass index (BMI) was calculated as weight in kg divided by
squared height in meters (kg/m2). Waist circumference (WC) was
measured to the nearest 0.1 cm at the level of the superior iliac
crest at the end of a normal expiration. Resting blood pressure and
pulse rate were measured with an oscillometric device (Dinamap
1846 SX/P; USA). Participants were seated in the examination
room for at least five minutes before blood pressure measurement,
and then an appropriately sized cuff was applied snugly around the
right upper arm at heart level. Cuff size was chosen for each
subject according to mid-arm circumference. Two readings at five
minute intervals were obtained and averaged to determine systolic
blood pressure (SBP) and diastolic blood pressure (DBP) for each
individual. When the two readings differed by $10 mmHg,
additional readings were obtained after five minutes, and the last
two readings were averaged.
An overnight fasting blood sample was collected after at least an
8-hour fast. Serum concentrations of total cholesterol, triglycer-
ides, high-density lipoprotein (HDL) cholesterol, aspartate amino-
transferase (AST), and alanine aminotransferase (ALT) were
measured by enzymatic methods with an autoanalyzer (7600
Autoanalyzer, Hitachi, Tokyo, Japan). Serum 25(OH)D was
measured by radioimmunoassay (BioSource, Nivelles, Belgium)
with inter-/intra-assay coefficient of variations (CVs) of 5.2% and
3.3%, respectively, and a reference range of 7.6 to 75.0 ng/ml.
Fasting plasma glucose (FPG) level was measured by the glucose
hexokinase method. Fasting plasma insulin level was measured by
the radio immunometric method. Insulin resistance was assessed
by homeostatic model assessment (HOMA-IR), calculated as the
product of the fasting insulin level (uIU/mL) and the fasting
glucose level (mg/dL), divided by 405.
Statistical analyses
All statistical analyses were performed separately for males and
females, because there were significant sex-differences in serum
Table 1. Participants characteristics.
Variable Total (n =260) Male (n =135) Female (n=125) p-value
Mean 6 SD
Age, year 15.960.3 15.960.3 15.960.3 0.274
Body mass index, kg/m2 21.762.9 22.263.2 21.262.5 0.011
Systolic blood pressure, mmHg 103.4611.5 109.4610.8 96.868.4 ,.001
Diastolic blood pressure, mmHg 57.965.9 58.466.1 57.465.8 0.204
Total cholesterol, mg/dl 156.9627.2 150.0626.6 164.5626.0 ,.001
HDL cholesterol, mg/dl 45.668.8 43.167.7 48.369.1 ,.001
Triglycerides, mg/dl 83.1630.3 85.6630.7 80.4629.8 0.066
Aspartate aminotransferase, IU/l 20.465.7 21.967.1 18.762.9 ,.001
Alanine aminotransferase, IU/l 15.969.2 18.5611.8 13.063.2 ,.001
Fasting glucose, mg/dl 84.566.2 86.066.3 82.965.8 ,.001
Fasting insulin, uIU/mL 8.5463.12 8.6763.44 8.4262.76 0.995
HOMA-IR, mg/dl/mL/uIU 1.7960.71 1.8660.79 1.7360.61 0.314
25(OH)D, ng/ml 15.867.2 17.066.9 14.467.3 ,.001
Number (%)
Smoking ($100 cigarettes) 13 (5.0) 12 (8.8) 1 (0.8) 0.546
Drinking ($1 time/month) 16 (6.1) 10 (7.4) 6 (4.8) 0.160
Regular exercise ($1 time/week) 219 (83.9) 120 (88.2) 99 (79.2) 0.003
Abbreviations: HDL, high-density lipoprotein; HOMA-IR, homeostasis model assessment insulin resistance.
doi:10.1371/journal.pone.0103108.t001
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25(OH)D levels and a significant interaction (p = 0.019) between
sex and 25(OH)D on HOMA-IR levels. Differences between
groups in quantitative variables were evaluated by student’s t-test,
x2-test, or Wilcoxon rank sum test. Spearman correlation and
linear regression analyses were used to examine the relationship
between variables. Both categorical (quartile groups) and contin-
uous measures of 25(OH)D were analyzed in association with
fasting glucose, insulin, and HOMA-IR levels, with and without
adjustment for age and sex. Multiple logistic regression models
were also used to evaluate the odds ratio and 95% confidence
interval for increased insulin resistance (defined as HOMA-IR
$75 percentile) for quartile groups of serum 25(OH)D as well as
for 10 ng/ml decrease of 25(OH)D. In order to assess the
independent association between serum 25(OH)D, two adjusted
models were employed; first for age and BMI, then for cigarette
smoking, alcohol consumption, and regular exercise. All analyses
were 2-tailed and performed using SAS system version 9.2 (SAS
Institute, Cary, NC, USA).
Results
The characteristics of the study participants are given by sex
and in total. Male participants had significantly higher BMI, SBP,
AST, ALT, FPG, and 25(OH)D, but significantly lower HDL
cholesterol level than female participants. None of the adolescents
had fasting glucose higher than 110 mg/dl. Thirteen adolescents
(5.0%) were current smokers, 16 (6.1%) consumed alcoholic drinks
at least once a month, and 219 (83.9%) exercised on a regular
basis (Table 1). Although the participants were recruited from a
single high school, their anthropometric distributions and serum
25(OH)D levels were similar to those in the 2007 Korean National
Growth Charts and the 2009 Korean National Health and
Nutrition Examination Survey. Mean height was 172.8/160.7 cm
(male/female) in this study, and the corresponding value from the
growth charts was 173.3/160.7 cm. Mean body weight was 66.4/
55.5 kg (male/female) in this study and 65.8/54.1 kg in the
growth charts. Mean serum 25(OH)D level was 17.0/14.4 ng/ml
(male/female) in this study and 17.2/16.4 ng/ml in the Korean
National Health and Nutrition Examination Survey [21,22].
Table 2 shows correlations between serum 25(OH)D and other
metabolic variables. Serum 25(OH)D level was inversely correlat-
ed with total cholesterol (r =20.213, p = 0.013), fasting insulin
(r =20.256, p = 0.003), and HOMA-IR (r =20.263, p = 0.002) in
males, but not in females. Figure 1 shows clear sex differences in
the linear relationship of serum 25(OH)D with fasting glucose,
insulin, and insulin resistance. Serum 25(OH)D level was
significantly and inversely associated with fasting insulin and
HOMA-IR only in male adolescents.
Table 3 shows fasting plasma glucose, insulin, and HOMA-IR
levels according to serum 25(OH)D. Male adolescents in the
lowest 25(OH)D quartile, when compared to those in the highest
quartile, had significantly higher fasting glucose (p = 0.039), fasting
insulin (p = 0.012), and HOMA-IR (p = 0.008) levels, even after
adjustment for age and BMI. There were also increasing trends in
fasting glucose (adjusted p for trend = 0.060), fasting insulin
(adjusted p for trend = 0.009), and HOMA-IR (adjusted p for
trend = 0.007) according to the decrease of 25(OH)D. When the
25(OH)D level was analyzed as a continuous variable, every
10 ng/ml lower level was associated with a 1.44 mg/dl increase in
fasting glucose, 1.02 uIU/mL increase in fasting insulin, and 0.25
unit increase in HOMA-IR among male adolescents. However, in
female adolescents, serum 25(OH)D level was not associated with
fasting glucose, insulin, or insulin resistance.T
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Table 4 presents the association between serum 25(OH)D level
and increased insulin resistance, which was defined as a HOMA-
IR value higher than the 75th percentile. In male adolescents, the
lowest 25(OH)D quartile was significantly associated with
increased insulin resistance, and this association was consistent
when unadjusted (odds ratio 4.06; 95% confidence interval 1.26 to
13.07), adjusted for age and body mass index (odds ratio 3.59;
95% CI 1.03 to 12.57), and adjusted for age, body mass index,
smoking, drinking, and regular exercise (odds ratio 3.54; 95% CI
1.01 to 12.41). Continuous measure of 25(OH)D level was also
significantly and inversely associated with insulin resistance among
male participants. However, this association was not observed
among female participants.
Discussion
We observed a significant inverse association between serum
25(OH)D level and insulin resistance in apparently healthy male
adolescents, but not in female adolescents. To our knowledge, this
is the first study demonstrating an association between a lower
serum 25(OH)D level and increased insulin resistance in healthy
Asian adolescents. Moreover, our study population has a narrow
age range (15 to 16 years), is relatively lean (mean body mass index
21.7 kg/m2), and free of metabolic disorders. These characteristics
minimized the possible influences of aging, obesity, and comor-
bidity in the relationship between vitamin D status and insulin
resistance. Most of previous studies on the association between
vitamin D and insulin resistance were performed in adult
populations [23–27]. A few observational studies and clinical
trials reported inverse associations between serum 25(OH)D and
insulin resistance among overweight or obese adolescents [16–19].
On the other hand, no association between serum 25(OH)D and
insulin resistance was observed among high school students in
Turkey [20]. A recent study reported a sigmoid-shaped association
between vitamin D and insulin resistance [27]. The inverse
association between 25(OH)D and insulin resistance was observed
only at serum 25(OH)D range from 16 to 36 ng/ml, but not at
25(OH)D values higher than 36 ng/ml or lower than 16 ng/ml
[27]. However, in our data, we could not observe such a sigmoid-
shaped association, probably because of small sample size or
narrow age distribution.
Our participants had relatively low serum 25(OH)D levels.
Mean serum 25(OH)D was 15.8 ng/ml, while mean serum
25(OH)D level was reported as 24 ng/ml among U.S. adolescents
Figure 1. Association between serum 25(OH)D level and glucose metabolism. Upper panels scatter plots with fitted regression lines for
25(OH)D versus fasting glucose, fasting insulin, and HOMA-IR, respectively in males. Lower panels are corresponding scatter plots with fitted
regression lines in females. P-values are for the regression coefficients.
doi:10.1371/journal.pone.0103108.g001
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aged 12 to 19 years [28]. Korean high school students devote large
amounts of time to studying, and many attend supplemental after-
school instruction [29], thus they may not receive sufficient
sunlight exposure for adequate cutaneous production of vitamin
D. However, we did not collect data on the amount of sunlight
exposure. Health effects of insufficient outdoor activity and
sunlight exposure need to be further investigated among Korean
adolescents. In this study, serum 25(OH)D level was associated
with insulin resistance in males, but not in females. This finding
suggests that female adolescents, even with vitamin D insufficien-
cy, maintain their insulin sensitivity. The developmental and
hormonal differences may explain, at least in part, the sex
difference in the associations between serum 25(OH)D level and
insulin resistance. Hormonal status during puberty, especially for
female adolescents, might affect glucose metabolism. The increase
in growth hormone during puberty may contribute to insulin
sensitivity via the growth hormone’s effect on increasing lipolysis
and free fatty acid concentration [30,31]. In addition, a rise in
estrogen level in females may suppress secretion of glucose and
protect the pancreatic insulin response to glucose [32]. The
relationship between vitamin D status and insulin resistance needs
to be further investigated across different sex and age groups.
Several limitations of our study should be acknowledged. First,
this is a cross-sectional study, thus the causal inference might be
limited. Second, we measured serum 25(OH)D level at a single
point, and therefore did not assess seasonal variation. However,
therefore seasonal variation is unlikely to distort the relationship
between 25(OH)D and insulin resistance, because the health
examination was performed over a relatively short period. Third,
we could not assess the effects of vitamin D supplements. Our
study population consisted of healthy high school students, and
none of them reported intake of vitamin D supplements. However,
we could not exclude the possible intake of a multivitamin formula
including vitamin D. Fourth, objective data on sun exposure and
time spent outdoors were not available. Thus, we could not
investigate the effects of sunlight on the relationship between
vitamin D status and insulin resistance. Finally, the study was
conducted at a single high school and included one ethnic group,
so the study findings cannot be generalized to other adolescent
populations.
In conclusion, this study suggests that lower serum 25(OH)D
levels may be associated with increased insulin resistance among
healthy male adolescents. Sex differences in the association
between serum 25(OH)D and insulin resistance need to be further
investigated.
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